Provide analysis of stocks, funds, and ETFs; interpret data on price, yield, stability, future investment-risk trends, economic influences, and other factors; and maintain liaison between brokers, agencies, banks, clearinghouses, and...
HPS Investment Partners is a leading global investment firm that seeks to provide creative capital solutions and generate attractive risk-adjusted returns for our clients. We manage various strategies across the capital structure, including...
Vacancy details General information Entity About Crédit Agricole Corporate and Investment Bank (Crédit Agricole CIB) Crédit Agricole CIB is the corporate and investment...
Vacancy details General information Entity About Crédit Agricole Corporate and Investment Bank (Crédit Agricole CIB) Crédit Agricole CIB is the corporate and investment...
Basic Qualifications: • Bachelor's degree with strong academic qualifications; MBA and/or CFA a plus. • Minimum of 5 years of relevant or similar experience in a credit role and strong preference for expertise covering banks and other...
Senior Treasury and Debt Analyst Posting Number 2024-14035 Location : Location US-NY-New York Hybrid Remote Work Classification Mostly Remote: Remote more than 60% of time Department ...
Job ID: 8784 Business Unit: MTA Headquarters Location: New York, NY, United States Regular/Temporary: Regular Department: Cash and...
Join JPMorgan Chase, a global leader in financial services with operations worldwide and assets of approximately $4 trillion. As part of our team, you'll have the opportunity to work in investment banking, financial services for consumers and...
GROUP DESCRIPTION: Jefferies Global Healthcare Group provides a full suite of advisory and capital markets capabilities to clients across several sectors, including healthcare services, pharma technology and services, biotechnology,...
About the job Investment Banking Analyst 2/3 Life Sciences/Biopharma M&A (Elite Boutique) Job Description Our client, an elite boutique investment bank, is actively seeking an Analyst 2/3 for their Healthcare M&A...